This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Biomerieux, Inc.. Active years: 2018-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2023
Title: Aurélie Thollet: Innovator in Blood Analysis Technology
Introduction
Aurélie Thollet is a notable inventor based in Nantes, France. He has made significant contributions to the field of blood analysis technology. With a focus on improving methods for measuring analytes in whole blood samples, Thollet has secured a total of 2 patents.
Latest Patents
Thollet's latest patents include a method for measuring the plasma concentration of an analyte directly on a whole blood sample. This innovative method involves several steps: measuring the haematocrit level of the whole blood sample, measuring the analyte amount directly in the whole blood sample, and calculating a corrected analyte amount using a specific polynomial relation. This approach enhances the accuracy of analyte measurements in clinical settings.
Career Highlights
Throughout his career, Aurélie Thollet has worked with prominent companies in the biotechnology sector, including bioMérieux, Inc. and BiomÉrieux. His experience in these organizations has allowed him to develop and refine his innovative techniques in blood analysis.
Collaborations
Thollet has collaborated with esteemed colleagues such as Sylvie Cheucle and Laure Marillet. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Aurélie Thollet stands out as an influential inventor in the field of blood analysis technology. His innovative methods and collaborations have the potential to significantly impact clinical practices in measuring analytes in whole blood samples.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
